In the present study we examined by Southern blot analysis the the incidence of deletions and rearrangements of p16 tumor- NHLs and suggest an association of p16 abnormalities with criteria is shown in Table 1 .
established depending on the histological subtype with chlorambucil and prednisone (n = 12), CHOP (n = 54), ProMACE/MOPP (n = 18), MACOP-B (n = 10) and LMB-86 Introduction (n = 9).
Experimental data support the view that carcinogenesis is a multistep process that involves activation of proto-oncogenes Immunophenotyping as well as inactivation of tumor-suppressor genes. [1] [2] [3] [4] Recently, the p16 gene has been added to the list of tumor-suppressor
The B cell lineage of the tumor cells was defined by CD79a genes based on several observations. Firstly, alterations in the and CD20 stainings on paraffin-embedded tisues, together p16 gene have been described in several types of cancer with a lack of reactivity for T cell and cytokeratin markers. (reviewed in Ref. 5) . Secondly, the p16 gene plays an A complete immunophenotype (CD5, CD10, CD19, CD22, important role in the control of the cell cycle, since its enco-CD23, CD25, CD103, CD71, FMC7 and SmIg) and DNA ded protein, p16, is able to inhibit the function of the complex quantitation of the tumor cells was obtained by flow formed by cyclin-dependent kinase 4 (CDK4) and D-type cytometry as previously described. 23, 24 cyclins, 6, 7 that controls the passage of cells through G1 phase. [8] [9] [10] Thirdly, the transfection of wild p16 into human glioma cells that lack endogenous p16 is able to suppress cell growth. 11 Within lymphoid malignancies, the p16 gene has
Tissue samples been shown to be altered in T and B lineage acute lymphoblastic leukemias, [12] [13] [14] [15] [16] [17] however, in B cell non-Hodgkin's lymOnly fresh samples with good quality DNA and at least 25% phomas (NHLs), the available information on the incidence neoplastic cells from lymph nodes, bone marrow or peripheral of p16 abnormalities and tumor subtype distribution is still blood samples were selected for the analysis. The number of scanty. 13, 18, 19 In addition, nothing is known about the influtumor cells was counted by flow cytometric analysis based on ence of p16 abnormalities on the survival of patients with their kappa/lambda and B cell antigen expression. 23, 24 In order NHL.
to confirm not only the B cell clonality of the disease but also In the present study, we examined by Southern blot analysis the presence of sufficient tumor cells in the sample, the presence of clonal B cells was also assessed by detection of IgH clonal gene rearrangements with Southern blot analysis using p16 and prognosis in lymphoma R García-Sanz et al
1916

DNA preparation and Southern blot (SB) analysis
This probe generates a 4.4 kb band in EcoRI fragments together with another weak band at 6.6 kb (fragment with exon 2 of the p15 gene). 18 In HindIII digests, three bands can be observed: High molecular weight DNA was isolated by standard proteinase K digestion, phenol-chloroform extraction and ethanol the main band at 10 kb (exons 2 and 3, p16 gene), and two weak bands at 23 kb (exon 2, p15 gene) and 6.6 kb (exon 1, precipitation. 26 For Southern blot analysis, 10 g of DNA was digested to completion with the EcoRI, HindIII and BglII p16 gene). 27 In order to confirm that the absence of p16 hybridizations were due to real p16 deletions and not to the restriction enzymes, size fractionated in 0.8% agarose gel, denatured, neutralized, and transferred to nylon membranes presence of insufficient DNA material in the slot, subsequent hybridizations with PFL-1 and PFL-2 genomic probes covering (Hybond-N+; Amersham, Little Chalfont, UK). The blots were hybridized with the appropriate Ready-to-go 32 P-labeled the MBR and mcr regions of the BCL-2 gene, respectively 28, 29 were employed for comparison with the p16 hybridization. probes according to the manufacturer's specifications (Readyto-go; Pharmacia Biotech, Uppsala, Sweden), washed twice Filters were analyzed by visual inspection and homozygous deletion was defined as a decrease of the signal of p16 adjusted in 0.5% SSC, 1% sodium dodecyl sulfate (SDS) for 30 minutes at 65°C, and autoradiographed between 48 and 96 h at to the percentage of tumor cells. These criteria can generate false negative results, but avoid false positive. Hemzygous deletions −80°C. The probe used in hybridizations was an 800-bp cDNA fragment covering the coding region of the p16 gene. 6 were not considered due to the methodology employed. 
Figure 2
Survival according p16 gene abnormalities.
Prognostic factors and statistical methods
Results
Seven cases displayed alterations of the p16 gene. In four To estimate the significance of the difference between cases with normal or abnormal p16 gene, the Mann-Whitney test cases, absence or very weak hybridization was observed for the p16 probe, with normal hybridization for the PFL-1 and was used using the SPSS software (SPSS Inc, Chicago, IL, USA). The 2 test (SPSS) was used for dicotomic variables. PFL-2 probes, indicating the presence of homozygous deletions of the p16 gene. Cases with weak signals could be Using univariate tests (Student t-test, 2 , and non-parametric tests; SPSS) the p16 gene status and the different clinical and explained by hybridization to DNA from contaminating normal cells. This was supported by the fact that in these cases biologic characteristics were considered individually for their effect on the probability of achieving complete remission after the percentage of tumor cells counted by flow cytometry was lower than 80%. In the other three cases, an extra band in a treatment. Subsequently, a multivariate analysis -stepwise regression (regression; SPSS) -was performed to examine the different position of the germline band was noted, indicating the presence of rearrangements of the p16 gene in these cases. simultaneous effect of the different variables on the probability of achieving complete remission.
The intensity of the extra band was proportional to the number of tumor cells counted by flow cytometry. No comigration The same characteristics were again considered for analysis of their individual and simultaneous effect on response durwas seen between p16 probe extrahybridizations and those generated with the JH6 probe. An example of both abnormaliation (RD) and overall survival (OS) -univariate and multivariate analysis, survival, SPSS, K-M and Cox regression, respectties is shown in Figure 1 . P16 alterations did not correlate with a particular histologic subgroup: three cases were small lymively. RD and OS curves were plotted according to the Kaplan and Meier method, and compared according to the Wilcoxon phocytic lymphomas (SLL), two diffuse large cell lymphomas (DLCL) and two small non-cleaved cell lymphomas (SNCCL). and log-rank tests. Variables considered for possible inclusion in the regression analysis were those displaying significant Two of the SLL were reclassified as mantle cell lymphomas (MCL) and one SNCCL was considered as a Burkitt-like lymassociation with survival in the univariate analysis (P Ͻ0.05) or for which previous studies had suggested a possible progphoma when the REAL classification criteria were employed (Table 1) . Considering only the nine cases of MCL in which nostic value. The stepwise regression method wass discontinued when the P value for entering an additional factor was there was one homozygous deletion and one rearrangement, there were two cases with the blastic variant. One of these above 0.05. Table 1 P16 gene abnormalities and histologic subtypes of the 103 NHLs studied according to the working formulation and REAL classifications
Working formulation
Real classification cases had a homozygous deletion of the p16 gene but the reactive protein Ͼ6 mg/dl, presence of B symptoms, Ͼ2.5% Sphase tumor cells, poor performance status (ECOG у2), poor other showed a normal hybridization of the p16 probe. The case with the rearrangement was a typical case of MCL. histologic picture (high or intermediate grade of WF), clinical stage IV, age above 75 years and presence of two or more Within the DLCL, no anaplastic large cell lymphomas were included, and the two cases that showed p16 lesions were extranodal sites involved (Table 2 ). In the multivariate analysis, the presence of p16 abnormalities retained an inde-CD30 negative.
Upon comparing the clinico-biological characteristics of pendent prognostic value and, together with the LDH and ␤ 2 -microglobulin provided the best combination of variables to patients with p16 abnormalities with the remaining 96 cases, the former group displayed higher mean age (70 ± 16 vs predict the survival in this series of NHL patients (Table 2) . Using the REAL classification, 21 two groups could be perfor-59 ± 17 years), ␤ 2 M serum levels (5.1 ± 3.2 vs 2.9 ± 2.1 mg/l), LDH serum levels (LDH above the normal limit in 71% vs med in accordance with their theoretical prognosis: one with good prognosis (SLL, FL and ML), and another one with a poor 38% of cases), more frequent bulky disease (43% vs 27% of cases) and poor performance status (57% vs 29% of cases).
prognosis (DLCL, MCL, Burkitt's lymphomas, Burkitt-like lymphomas, precursor cell lymphomas and unclassified Nevertheless, none of these differences reached statistical significance, probably due to the low number of patients with lymphomas). In our series, the first group included 59 patients and the second one 44, and they effectively had a different p16 abnormalities. Curiously, all seven patients were male, while in the group with a normal p16 gene, males made up survival (Table 2) . Interestingly, six out of the seven cases with p16 gene lesions were in the group with a poorer survival. 54% (P = 0.02). No correlation between p16 abnormalities and immunophenotyping was observed. A lower rate of comUpon considering for the analysis only the 44 cases with aggressive histologies, p16 lesions were also associated with plete remission was also noted (28% vs 47%), and the two patients with p16 abnormalities who achieved CR rapidly a shorter survival (6 vs 81 months, P = 0.0011) and were selected on the multivariate analysis as an independent factor relapsed. The survival analysis confirmed the poor prognosis of the seven cases with p16 gene alterations. Thus, the median (P = 0.0126) after LDH serum levels (P = 0.0101). The ␤ 2 M was the third variable selected in the model, but without survival was 10 months for these patients compared with 81 months in the group with a normal p16 gene (Wilcoxon, statistical significance (P = 0.0824). P = 0.0006, log rank, P = 0.0001) (Figure 2 ).
In the whole series, the analysis of prognostic factors for Discussion overall survival revealed that in addition to p16 gene abnormalities, another 10 clinico-biological characteristics correTumor suppressor genes, like p53, have been found to be involved in hematologic malignancies, frequently correlating lated with poor prognosis: ␤ 2 M Ͼ 6 mg/l, LDH Ͼ 460 U/l, C- Table 2 Prognostic factors selected with respect to overall survival paper, have found p16 lesions in other histological subtypes. 13, 15, 27 The main mechanism responsible for p16 gene showed that p16 deletion/rearrangement is an independent lymphoma; PCL, precursor cell lymphoma.
prognostic indicator in NHLs. This parameter, together with ␤ 2 microglobulin and LDH, contributes to define patients with poor outcome. with progression from indolent to aggressive disease (reviewed in Ref. 30). The recently described gene p16, also known as
In conclusion, we provide evidence that supports a role for the p16 tumor-suppressor gene in the pathogenesis and clini-MTS1 or multiple tumor suppressor gene, has also been shown to be altered in acute lymphoblastic leukemias, in both cal behavior of NHLs. Thus, p16 lesions, generated through deletions or rearrangements, can be present at the moment of T and B cell lineages (reviewed in Ref. 5 ), which could suggest that this gene plays an important role in the pathogenesis of diagnosis and are associated with poor prognosis. lymphoid malignancies. However, in B cell NHLs the information about the p16 gene is relatively scanty and sometimes contradictory regarding both the incidence and histological distribution. 13, 15, 16, 18, 19, 27, 31 The incidence of p16 abnormaliAcknowledgements ties found in our series (7%) represents an intermediate value with respect to those published in previous literature, which ranges between 0 and 17%. 13, 15, 16, 18, 19, 27, 30 No correlation of This work has been partially supported by grants number 94/1564 and 96/1233 from the Fondo de Investigaciones Sanip16 deletion/rearrangement with histopathology was found. Koduru et al 18 reported that p16 gene abnormalities were tarias de la Seguridad Social of the Ministerio de Sanidad y Consumo (Spain). exclusively present in DLCL, but other reports, including this
